Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04529824 · ClinicalTrials.gov registry record
Glucose Risk Assessment in Employer Populations
A clinical trial of Diabetes and Pre Diabetes, sponsored by DexCom.
- Completed
- Registry status
- 207
- Enrollment target
- 1
- Study location
NCT04529824 is a study of Diabetes and Pre Diabetes that has completed, run by DexCom. The registered enrollment target is 207 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04529824, a study of Diabetes and Pre Diabetes, has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- 207 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study to understand the glucose characteristics of the general population (normal glucose, pre-diabetes, and diabetes). Glucose risk will be measured with laboratory HbA1c and continuous glucose monitor (CGM) derived metrics. Physical activity will also be measured using a Fitbit activity tracker. The study will inform future programs that use CGM and activity tracking to identify people at risk for diabetes in the population.
Conditions Studied
Interventions
- DEVICE Dexcom G6 Continuous Glucose Monitor (CGM) System
Study Locations (1)
Florida
- Lakeland Clinic - Lakeland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2021-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04529824
The ClinicalTrials.gov registry entry for NCT04529824 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (93% lower). The listed sponsor is DexCom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Dexcom G6 Continuous Glucose Monitor (CGM) System is the first listed.
NCT04529824 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04529824 about?
NCT04529824 is a clinical study titled "Glucose Risk Assessment in Employer Populations". This is an observational study to understand the glucose characteristics of the general population (normal glucose, pre-diabetes, and diabetes). Glucose risk will be measured with laboratory HbA1c and continuous glucose monitor (CGM) derived metrics. Physical activity will also be measured using a F...
What is the current status of trial NCT04529824?
This trial is currently completed. The enrollment target is 207 participants. The study started on 2019-04-01. Estimated completion is 2021-08-01.
What conditions does trial NCT04529824 study?
This clinical trial studies the following conditions: Diabetes, Pre Diabetes, Glucose Intolerance.
What interventions are being tested in trial NCT04529824?
The interventions under investigation include: Dexcom G6 Continuous Glucose Monitor (CGM) System (DEVICE).
Who is sponsoring clinical trial NCT04529824?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04529824 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.